Skip to search.
 TSX Down 1.74% TSX Ventures Up 0.46%

Incyte Corporation (INCY)

-NasdaqGS
67.90 Down 3.10(4.37%) 1:56PM EST - Nasdaq Real Time Price
Prev Close:71.00
Open:69.50
Bid:67.73 x 100
Ask:67.90 x 100
1y Target Est:116.77
Beta:0.68688
Next Earnings Date:11-Feb-16INCY Earnings announcement
Day's Range:65.61 - 70.44
52wk Range:64.51 - 133.62
Volume:1,931,947
Avg Vol (3m):1,972,820
Market Cap:12.63B
P/E (ttm):N/A
EPS (ttm):-0.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INCYDown 4.37%12.63B
CELGUp 0.66%77.42B
AMGNDown 2.94%106.14B

Key Statistics

Forward P/E (1 yr):109.27
P/S (ttm):20.83
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.19
Quarterly EPS Est (Dec-15) :0.08
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-7.01

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics primarily for oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback